Vascular Biology |
From the Department of Vascular Biology and Thrombosis Research (F.G., B.R.B., R.d.M.), the Clinical Institute of Medical and Chemical Laboratory Diagnostics, and Ludwig Boltzmann Institute of Clinical Experimental Oncology (M.B., O.W.), University of Vienna, Austria; and the Competence Center Biomolecular Therapeutics GmbH (H.M., V.K.), Vienna, Austria.
Correspondence to Rainer de Martin, PhD, Department of Vascular Biology and Thrombosis Research, University of Vienna, Brunnerstr 59, A-1235 Vienna, Austria. E-mail rainer.de.martin{at}univie.ac.at
Objective Endothelial cells comprise a key component of the inflammatory response. We set out to obtain a comprehensive overview of the immediate-early to early gene expression program of interleukin-1 (IL-1)stimulated endothelial cells and to identify novel transcription factors and regulatory elements.
Methods and Results Human umbilical vein endothelial cells (HUVECs) were stimulated with IL-1 for 0, 0.5, 1, 2.5, and 6 hours and analyzed using Affymetrix U133 microarrays. A total of 137 genes were found to be regulated >4-fold, including 18 transcription factors. The expression of selected genes was confirmed by real-time polymerase chain reaction. Cluster analysis was performed in order to group genes according to their expression profiles. To identify novel transcription factorbinding sites, the corresponding promoters were extracted from databases and analyzed for regulatory elements that were over-represented in specific clusters. Several potentially novel DNA binding sites were identified, and one was shown to specifically bind an IL-1inducible protein from HUVEC.
Conclusions These results demonstrate that in the early phase after stimulation, IL-1 evokes a complex gene expression program that includes positive but also negative (feedback) regulators of diverse endothelial cell functions. Furthermore, the identification of a new promoter regulatory element demonstrates the feasibility of the bioinformatics-driven approach to discover novel regulatory mechanisms.
We analyzed the early gene expression program of IL-1stimulated ECs using microarray technology, particularly focusing on TF profiles. Furthermore, large-scale bioinformatic comparisons of promoter sequence sets led to the identification of a novel DNA binding site that was shown to specifically bind an IL-1inducible protein.
Key Words: endothelial cells inflammation interleukin-1 microarrays transcription factors
This article has been cited by other articles:
![]() |
C Hamid, K Norgate, D P D'Cruz, M A Khamashta, M Arno, J D Pearson, G Frampton, and J J Murphy Anti-{beta}2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome Ann Rheum Dis, August 1, 2007; 66(8): 1000 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. J. Florey, M. Johns, O. O. Esho, J. C. Mason, and D. O. Haskard Antiendothelial cell antibodies mediate enhanced leukocyte adhesion to cytokine-activated endothelial cells through a novel mechanism requiring cooperation between Fc{gamma}RIIa and CXCR1/2 Blood, May 1, 2007; 109(9): 3881 - 3889. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nagao, M. Matsumura, A. Mabuchi, A. Ishida-Okawara, O. Koshio, T. Nakayama, H. Minamitani, and K. Suzuki Up-regulation of adhesion molecule expression in glomerular endothelial cells by anti-myeloperoxidase antibody Nephrol. Dial. Transplant., January 1, 2007; 22(1): 77 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Vasarhelyi, A. Cseh, I. Kocsis, A. Treszl, B. Gyorffy, and J. Rigo Jr Three mechanisms in the pathogenesis of pre-eclampsia suggested by over-represented transcription factor-binding sites detected with comparative promoter analysis Mol. Hum. Reprod., January 1, 2006; 12(1): 31 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Aerts, P. Van Loo, G. Thijs, H. Mayer, R. de Martin, Y. Moreau, and B. De Moor TOUCAN 2: the all-inclusive open source workbench for regulatory sequence analysis Nucleic Acids Res., July 1, 2005; 33(suppl_2): W393 - W396. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |